These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 34786565)

  • 1. All hands on deck: SARS-CoV-2 proteins that block early anti-viral interferon responses.
    Setaro AC; Gaglia MM
    Curr Res Virol Sci; 2021; 2():100015. PubMed ID: 34786565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evasion of Type I Interferon by SARS-CoV-2.
    Xia H; Cao Z; Xie X; Zhang X; Chen JY; Wang H; Menachery VD; Rajsbaum R; Shi PY
    Cell Rep; 2020 Oct; 33(1):108234. PubMed ID: 32979938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus.
    Devaraj SG; Wang N; Chen Z; Chen Z; Tseng M; Barretto N; Lin R; Peters CJ; Tseng CT; Baker SC; Li K
    J Biol Chem; 2007 Nov; 282(44):32208-21. PubMed ID: 17761676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways.
    Deng J; Zheng Y; Zheng SN; Nan ML; Han L; Zhang J; Jin Y; Pan JA; Gao C; Wang PH
    J Med Virol; 2023 Mar; 95(3):e28561. PubMed ID: 36755358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases.
    Larionova R; Byvaltsev K; Kravtsova О; Takha E; Petrov S; Kazarian G; Valeeva A; Shuralev E; Mukminov M; Renaudineau Y; Arleevskaya M
    J Transl Autoimmun; 2022; 5():100154. PubMed ID: 35434592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papain-like protease of SARS-CoV-2 inhibits RLR signaling in a deubiquitination-dependent and deubiquitination-independent manner.
    Ran XH; Zhu JW; Chen YY; Ni RZ; Mu D
    Front Immunol; 2022; 13():947272. PubMed ID: 36032116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.
    Moustaqil M; Ollivier E; Chiu HP; Van Tol S; Rudolffi-Soto P; Stevens C; Bhumkar A; Hunter DJB; Freiberg AN; Jacques D; Lee B; Sierecki E; Gambin Y
    Emerg Microbes Infect; 2021 Dec; 10(1):178-195. PubMed ID: 33372854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection.
    Li M; Ayyanathan K; Dittmar M; Miller J; Tapescu I; Lee JS; McGrath ME; Xue Y; Vashee S; Schultz DC; Frieman MB; Cherry S
    mBio; 2023 Aug; 14(4):e0119423. PubMed ID: 37377442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles and functions of SARS-CoV-2 proteins in host immune evasion.
    Rashid F; Xie Z; Suleman M; Shah A; Khan S; Luo S
    Front Immunol; 2022; 13():940756. PubMed ID: 36003396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
    Kumar A; Ishida R; Strilets T; Cole J; Lopez-Orozco J; Fayad N; Felix-Lopez A; Elaish M; Evseev D; Magor KE; Mahal LK; Nagata LP; Evans DH; Hobman TC
    J Virol; 2021 Jun; 95(13):e0026621. PubMed ID: 34110264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling.
    Zheng Y; Zhuang MW; Han L; Zhang J; Nan ML; Zhan P; Kang D; Liu X; Gao C; Wang PH
    Signal Transduct Target Ther; 2020 Dec; 5(1):299. PubMed ID: 33372174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon.
    Shemesh M; Aktepe TE; Deerain JM; McAuley JL; Audsley MD; David CT; Purcell DFJ; Urin V; Hartmann R; Moseley GW; Mackenzie JM; Schreiber G; Harari D
    PLoS Pathog; 2021 Aug; 17(8):e1009800. PubMed ID: 34437657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.
    Oh SJ; Shin OS
    Cells; 2021 Mar; 10(3):. PubMed ID: 33801464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway.
    Li JY; Liao CH; Wang Q; Tan YJ; Luo R; Qiu Y; Ge XY
    Virus Res; 2020 Sep; 286():198074. PubMed ID: 32589897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An anti-interferon activity shared by paramyxovirus C proteins: inhibition of Toll-like receptor 7/9-dependent alpha interferon induction.
    Yamaguchi M; Kitagawa Y; Zhou M; Itoh M; Gotoh B
    FEBS Lett; 2014 Jan; 588(1):28-34. PubMed ID: 24269682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and evasion of type I interferon responses by SARS-CoV-2.
    Lei X; Dong X; Ma R; Wang W; Xiao X; Tian Z; Wang C; Wang Y; Li L; Ren L; Guo F; Zhao Z; Zhou Z; Xiang Z; Wang J
    Nat Commun; 2020 Jul; 11(1):3810. PubMed ID: 32733001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.
    Chen J; Li Z; Guo J; Xu S; Zhou J; Chen Q; Tong X; Wang D; Peng G; Fang L; Xiao S
    J Virol; 2022 Apr; 96(8):e0003722. PubMed ID: 35389264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion.
    Gori Savellini G; Anichini G; Gandolfo C; Cusi MG
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage display technique identifies the interaction of severe acute respiratory syndrome coronavirus open reading frame 6 protein with nuclear pore complex interacting protein NPIPB3 in modulating Type I interferon antagonism.
    Huang SH; Lee TY; Lin YJ; Wan L; Lai CH; Lin CW
    J Microbiol Immunol Infect; 2017 Jun; 50(3):277-285. PubMed ID: 26320399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.